The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Folic Acid Tablets Market Research Report 2025
Synopsis
Folic acid, also known as folate or Vitamin B9, is a member of the B vitamin family and an essential cofactor for enzymes involved in DNA and RNA synthesis. More specifically, folic acid is required by the body for the synthesis of purines, pyrimidines, and methionine before incorporation into DNA or protein. Folic acid is particularly important during phases of rapid cell division, such as infancy, pregnancy, and erythropoiesis, and plays a protective factor in the development of cancer. As humans are unable to synthesize folic acid endogenously, diet and supplementation is necessary to prevent deficiencies. For example, folic acid is present in green vegetables, beans, avocado, and some fruits.
The global Folic Acid Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In order to function within the body, folic acid must first be reduced by the enzyme dihydrofolate reductase (DHFR) into the cofactors dihydrofolate (DHF) and tetrahydrofolate (THF). This important pathway, which is required for de novo synthesis of nucleic acids and amino acids, is disrupted by anti-metabolite therapies such as Methotrexate as they function as DHFR inhibitors to prevent DNA synthesis in rapidly dividing cells, and therefore prevent the formation of DHF and THF. When used in high doses such as for cancer therapy, or in low doses such as for Rheumatoid Arthritis or psoriasis, Methotrexate impedes the body's ability to create folic acid. This results in a deficiency of coenzymes and a resultant buildup of toxic substances that are responsible for numerous adverse side effects. As a result, supplementation with 1-5mg of folic acid is recommended to prevent deficiency and a number of side effects associated with MTX therapy including mouth ulcers and gastrointestinal irritation. Leucovorin (also known as folinic acid) supplementation is typically used for high-dose MTX regimens for the treatment of cancer. Levoleucovorin and leucovorin are analogs of tetrahydrofolate (THF) and are able to bypass DHFR reduction to act as a cellular replacement for the co-factor THF.
This report aims to provide a comprehensive presentation of the global market for Folic Acid Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Folic Acid Tablets.
Report Scope
The Folic Acid Tablets market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Folic Acid Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Folic Acid Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
A＆Z Pharmaceutical
Endo International
Cardinal Health
Leading Pharma, LLC
Meiaojian
Sunota
Scrianen
Fishburg
Meydunlg
Elevit
Natures Bounty
Forceval
Nutrilite
Osteroform
Ferguson
By-Health
Lisheng Pharmaceutical
Renhe Pharmacy
SAN JIU ENTERPRISE GROUP
Segment by Type
1mg
5mg
Other
Segment by Application
Pregnancy Lady
Pregnant Lady
Lactating Lady
Child
Men
General
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Folic Acid Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Folic Acid Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Folic acid, also known as folate or Vitamin B9, is a member of the B vitamin family and an essential cofactor for enzymes involved in DNA and RNA synthesis. More specifically, folic acid is required by the body for the synthesis of purines, pyrimidines, and methionine before incorporation into DNA or protein. Folic acid is particularly important during phases of rapid cell division, such as infancy, pregnancy, and erythropoiesis, and plays a protective factor in the development of cancer. As humans are unable to synthesize folic acid endogenously, diet and supplementation is necessary to prevent deficiencies. For example, folic acid is present in green vegetables, beans, avocado, and some fruits.
The global Folic Acid Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In order to function within the body, folic acid must first be reduced by the enzyme dihydrofolate reductase (DHFR) into the cofactors dihydrofolate (DHF) and tetrahydrofolate (THF). This important pathway, which is required for de novo synthesis of nucleic acids and amino acids, is disrupted by anti-metabolite therapies such as Methotrexate as they function as DHFR inhibitors to prevent DNA synthesis in rapidly dividing cells, and therefore prevent the formation of DHF and THF. When used in high doses such as for cancer therapy, or in low doses such as for Rheumatoid Arthritis or psoriasis, Methotrexate impedes the body's ability to create folic acid. This results in a deficiency of coenzymes and a resultant buildup of toxic substances that are responsible for numerous adverse side effects. As a result, supplementation with 1-5mg of folic acid is recommended to prevent deficiency and a number of side effects associated with MTX therapy including mouth ulcers and gastrointestinal irritation. Leucovorin (also known as folinic acid) supplementation is typically used for high-dose MTX regimens for the treatment of cancer. Levoleucovorin and leucovorin are analogs of tetrahydrofolate (THF) and are able to bypass DHFR reduction to act as a cellular replacement for the co-factor THF.
This report aims to provide a comprehensive presentation of the global market for Folic Acid Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Folic Acid Tablets.
Report Scope
The Folic Acid Tablets market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Folic Acid Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Folic Acid Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
A＆Z Pharmaceutical
Endo International
Cardinal Health
Leading Pharma, LLC
Meiaojian
Sunota
Scrianen
Fishburg
Meydunlg
Elevit
Natures Bounty
Forceval
Nutrilite
Osteroform
Ferguson
By-Health
Lisheng Pharmaceutical
Renhe Pharmacy
SAN JIU ENTERPRISE GROUP
Segment by Type
1mg
5mg
Other
Segment by Application
Pregnancy Lady
Pregnant Lady
Lactating Lady
Child
Men
General
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Folic Acid Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Folic Acid Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Folic Acid Tablets Market Overview
1.1 Product Overview and Scope of Folic Acid Tablets
1.2 Folic Acid Tablets Segment by Type
1.2.1 Global Folic Acid Tablets Market Value Comparison by Type (2024-2030)
1.2.2 1mg
1.2.3 5mg
1.2.4 Other
1.3 Folic Acid Tablets Segment by Application
1.3.1 Global Folic Acid Tablets Market Value by Application: (2024-2030)
1.3.2 Pregnancy Lady
1.3.3 Pregnant Lady
1.3.4 Lactating Lady
1.3.5 Child
1.3.6 Men
1.3.7 General
1.3.8 Other
1.4 Global Folic Acid Tablets Market Size Estimates and Forecasts
1.4.1 Global Folic Acid Tablets Revenue 2019-2030
1.4.2 Global Folic Acid Tablets Sales 2019-2030
1.4.3 Global Folic Acid Tablets Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Folic Acid Tablets Market Competition by Manufacturers
2.1 Global Folic Acid Tablets Sales Market Share by Manufacturers (2019-2024)
2.2 Global Folic Acid Tablets Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Folic Acid Tablets Average Price by Manufacturers (2019-2024)
2.4 Global Folic Acid Tablets Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Folic Acid Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Folic Acid Tablets, Product Type & Application
2.7 Folic Acid Tablets Market Competitive Situation and Trends
2.7.1 Folic Acid Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Folic Acid Tablets Players Market Share by Revenue
2.7.3 Global Folic Acid Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Folic Acid Tablets Retrospective Market Scenario by Region
3.1 Global Folic Acid Tablets Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Folic Acid Tablets Global Folic Acid Tablets Sales by Region: 2019-2030
3.2.1 Global Folic Acid Tablets Sales by Region: 2019-2024
3.2.2 Global Folic Acid Tablets Sales by Region: 2025-2030
3.3 Global Folic Acid Tablets Global Folic Acid Tablets Revenue by Region: 2019-2030
3.3.1 Global Folic Acid Tablets Revenue by Region: 2019-2024
3.3.2 Global Folic Acid Tablets Revenue by Region: 2025-2030
3.4 North America Folic Acid Tablets Market Facts & Figures by Country
3.4.1 North America Folic Acid Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Folic Acid Tablets Sales by Country (2019-2030)
3.4.3 North America Folic Acid Tablets Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Folic Acid Tablets Market Facts & Figures by Country
3.5.1 Europe Folic Acid Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Folic Acid Tablets Sales by Country (2019-2030)
3.5.3 Europe Folic Acid Tablets Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Folic Acid Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Folic Acid Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Folic Acid Tablets Sales by Country (2019-2030)
3.6.3 Asia Pacific Folic Acid Tablets Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Folic Acid Tablets Market Facts & Figures by Country
3.7.1 Latin America Folic Acid Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Folic Acid Tablets Sales by Country (2019-2030)
3.7.3 Latin America Folic Acid Tablets Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Folic Acid Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Folic Acid Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Folic Acid Tablets Sales by Country (2019-2030)
3.8.3 Middle East and Africa Folic Acid Tablets Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Folic Acid Tablets Sales by Type (2019-2030)
4.1.1 Global Folic Acid Tablets Sales by Type (2019-2024)
4.1.2 Global Folic Acid Tablets Sales by Type (2025-2030)
4.1.3 Global Folic Acid Tablets Sales Market Share by Type (2019-2030)
4.2 Global Folic Acid Tablets Revenue by Type (2019-2030)
4.2.1 Global Folic Acid Tablets Revenue by Type (2019-2024)
4.2.2 Global Folic Acid Tablets Revenue by Type (2025-2030)
4.2.3 Global Folic Acid Tablets Revenue Market Share by Type (2019-2030)
4.3 Global Folic Acid Tablets Price by Type (2019-2030)
5 Segment by Application
5.1 Global Folic Acid Tablets Sales by Application (2019-2030)
5.1.1 Global Folic Acid Tablets Sales by Application (2019-2024)
5.1.2 Global Folic Acid Tablets Sales by Application (2025-2030)
5.1.3 Global Folic Acid Tablets Sales Market Share by Application (2019-2030)
5.2 Global Folic Acid Tablets Revenue by Application (2019-2030)
5.2.1 Global Folic Acid Tablets Revenue by Application (2019-2024)
5.2.2 Global Folic Acid Tablets Revenue by Application (2025-2030)
5.2.3 Global Folic Acid Tablets Revenue Market Share by Application (2019-2030)
5.3 Global Folic Acid Tablets Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer Folic Acid Tablets Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 A＆Z Pharmaceutical
6.2.1 A＆Z Pharmaceutical Corporation Information
6.2.2 A＆Z Pharmaceutical Description and Business Overview
6.2.3 A＆Z Pharmaceutical Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.2.4 A＆Z Pharmaceutical Folic Acid Tablets Product Portfolio
6.2.5 A＆Z Pharmaceutical Recent Developments/Updates
6.3 Endo International
6.3.1 Endo International Corporation Information
6.3.2 Endo International Description and Business Overview
6.3.3 Endo International Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Endo International Folic Acid Tablets Product Portfolio
6.3.5 Endo International Recent Developments/Updates
6.4 Cardinal Health
6.4.1 Cardinal Health Corporation Information
6.4.2 Cardinal Health Description and Business Overview
6.4.3 Cardinal Health Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cardinal Health Folic Acid Tablets Product Portfolio
6.4.5 Cardinal Health Recent Developments/Updates
6.5 Leading Pharma, LLC
6.5.1 Leading Pharma, LLC Corporation Information
6.5.2 Leading Pharma, LLC Description and Business Overview
6.5.3 Leading Pharma, LLC Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Leading Pharma, LLC Folic Acid Tablets Product Portfolio
6.5.5 Leading Pharma, LLC Recent Developments/Updates
6.6 Meiaojian
6.6.1 Meiaojian Corporation Information
6.6.2 Meiaojian Description and Business Overview
6.6.3 Meiaojian Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Meiaojian Folic Acid Tablets Product Portfolio
6.6.5 Meiaojian Recent Developments/Updates
6.7 Sunota
6.6.1 Sunota Corporation Information
6.6.2 Sunota Description and Business Overview
6.6.3 Sunota Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sunota Folic Acid Tablets Product Portfolio
6.7.5 Sunota Recent Developments/Updates
6.8 Scrianen
6.8.1 Scrianen Corporation Information
6.8.2 Scrianen Description and Business Overview
6.8.3 Scrianen Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Scrianen Folic Acid Tablets Product Portfolio
6.8.5 Scrianen Recent Developments/Updates
6.9 Fishburg
6.9.1 Fishburg Corporation Information
6.9.2 Fishburg Description and Business Overview
6.9.3 Fishburg Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Fishburg Folic Acid Tablets Product Portfolio
6.9.5 Fishburg Recent Developments/Updates
6.10 Meydunlg
6.10.1 Meydunlg Corporation Information
6.10.2 Meydunlg Description and Business Overview
6.10.3 Meydunlg Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Meydunlg Folic Acid Tablets Product Portfolio
6.10.5 Meydunlg Recent Developments/Updates
6.11 Elevit
6.11.1 Elevit Corporation Information
6.11.2 Elevit Folic Acid Tablets Description and Business Overview
6.11.3 Elevit Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Elevit Folic Acid Tablets Product Portfolio
6.11.5 Elevit Recent Developments/Updates
6.12 Natures Bounty
6.12.1 Natures Bounty Corporation Information
6.12.2 Natures Bounty Folic Acid Tablets Description and Business Overview
6.12.3 Natures Bounty Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Natures Bounty Folic Acid Tablets Product Portfolio
6.12.5 Natures Bounty Recent Developments/Updates
6.13 Forceval
6.13.1 Forceval Corporation Information
6.13.2 Forceval Folic Acid Tablets Description and Business Overview
6.13.3 Forceval Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Forceval Folic Acid Tablets Product Portfolio
6.13.5 Forceval Recent Developments/Updates
6.14 Nutrilite
6.14.1 Nutrilite Corporation Information
6.14.2 Nutrilite Folic Acid Tablets Description and Business Overview
6.14.3 Nutrilite Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Nutrilite Folic Acid Tablets Product Portfolio
6.14.5 Nutrilite Recent Developments/Updates
6.15 Osteroform
6.15.1 Osteroform Corporation Information
6.15.2 Osteroform Folic Acid Tablets Description and Business Overview
6.15.3 Osteroform Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Osteroform Folic Acid Tablets Product Portfolio
6.15.5 Osteroform Recent Developments/Updates
6.16 Ferguson
6.16.1 Ferguson Corporation Information
6.16.2 Ferguson Folic Acid Tablets Description and Business Overview
6.16.3 Ferguson Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Ferguson Folic Acid Tablets Product Portfolio
6.16.5 Ferguson Recent Developments/Updates
6.17 By-Health
6.17.1 By-Health Corporation Information
6.17.2 By-Health Folic Acid Tablets Description and Business Overview
6.17.3 By-Health Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.17.4 By-Health Folic Acid Tablets Product Portfolio
6.17.5 By-Health Recent Developments/Updates
6.18 Lisheng Pharmaceutical
6.18.1 Lisheng Pharmaceutical Corporation Information
6.18.2 Lisheng Pharmaceutical Folic Acid Tablets Description and Business Overview
6.18.3 Lisheng Pharmaceutical Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Lisheng Pharmaceutical Folic Acid Tablets Product Portfolio
6.18.5 Lisheng Pharmaceutical Recent Developments/Updates
6.19 Renhe Pharmacy
6.19.1 Renhe Pharmacy Corporation Information
6.19.2 Renhe Pharmacy Folic Acid Tablets Description and Business Overview
6.19.3 Renhe Pharmacy Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Renhe Pharmacy Folic Acid Tablets Product Portfolio
6.19.5 Renhe Pharmacy Recent Developments/Updates
6.20 SAN JIU ENTERPRISE GROUP
6.20.1 SAN JIU ENTERPRISE GROUP Corporation Information
6.20.2 SAN JIU ENTERPRISE GROUP Folic Acid Tablets Description and Business Overview
6.20.3 SAN JIU ENTERPRISE GROUP Folic Acid Tablets Sales, Revenue and Gross Margin (2019-2024)
6.20.4 SAN JIU ENTERPRISE GROUP Folic Acid Tablets Product Portfolio
6.20.5 SAN JIU ENTERPRISE GROUP Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Folic Acid Tablets Industry Chain Analysis
7.2 Folic Acid Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Folic Acid Tablets Production Mode & Process
7.4 Folic Acid Tablets Sales and Marketing
7.4.1 Folic Acid Tablets Sales Channels
7.4.2 Folic Acid Tablets Distributors
7.5 Folic Acid Tablets Customers
8 Folic Acid Tablets Market Dynamics
8.1 Folic Acid Tablets Industry Trends
8.2 Folic Acid Tablets Market Drivers
8.3 Folic Acid Tablets Market Challenges
8.4 Folic Acid Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Folic Acid Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Folic Acid Tablets Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Folic Acid Tablets Market Competitive Situation by Manufacturers in 2023
Table 4. Global Folic Acid Tablets Sales (M Pcs) of Key Manufacturers (2019-2024)
Table 5. Global Folic Acid Tablets Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Folic Acid Tablets Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Folic Acid Tablets Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Folic Acid Tablets Average Price (US$/Pcs) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Folic Acid Tablets, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Folic Acid Tablets, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Folic Acid Tablets, Product Type & Application
Table 12. Global Key Manufacturers of Folic Acid Tablets, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Folic Acid Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Folic Acid Tablets as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Folic Acid Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Folic Acid Tablets Sales by Region (2019-2024) & (M Pcs)
Table 18. Global Folic Acid Tablets Sales Market Share by Region (2019-2024)
Table 19. Global Folic Acid Tablets Sales by Region (2025-2030) & (M Pcs)
Table 20. Global Folic Acid Tablets Sales Market Share by Region (2025-2030)
Table 21. Global Folic Acid Tablets Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Folic Acid Tablets Revenue Market Share by Region (2019-2024)
Table 23. Global Folic Acid Tablets Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Folic Acid Tablets Revenue Market Share by Region (2025-2030)
Table 25. North America Folic Acid Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Folic Acid Tablets Sales by Country (2019-2024) & (M Pcs)
Table 27. North America Folic Acid Tablets Sales by Country (2025-2030) & (M Pcs)
Table 28. North America Folic Acid Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Folic Acid Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Folic Acid Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Folic Acid Tablets Sales by Country (2019-2024) & (M Pcs)
Table 32. Europe Folic Acid Tablets Sales by Country (2025-2030) & (M Pcs)
Table 33. Europe Folic Acid Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Folic Acid Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Folic Acid Tablets Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Folic Acid Tablets Sales by Region (2019-2024) & (M Pcs)
Table 37. Asia Pacific Folic Acid Tablets Sales by Region (2025-2030) & (M Pcs)
Table 38. Asia Pacific Folic Acid Tablets Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Folic Acid Tablets Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Folic Acid Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Folic Acid Tablets Sales by Country (2019-2024) & (M Pcs)
Table 42. Latin America Folic Acid Tablets Sales by Country (2025-2030) & (M Pcs)
Table 43. Latin America Folic Acid Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Folic Acid Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Folic Acid Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Folic Acid Tablets Sales by Country (2019-2024) & (M Pcs)
Table 47. Middle East & Africa Folic Acid Tablets Sales by Country (2025-2030) & (M Pcs)
Table 48. Middle East & Africa Folic Acid Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Folic Acid Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Folic Acid Tablets Sales (M Pcs) by Type (2019-2024)
Table 51. Global Folic Acid Tablets Sales (M Pcs) by Type (2025-2030)
Table 52. Global Folic Acid Tablets Sales Market Share by Type (2019-2024)
Table 53. Global Folic Acid Tablets Sales Market Share by Type (2025-2030)
Table 54. Global Folic Acid Tablets Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Folic Acid Tablets Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Folic Acid Tablets Revenue Market Share by Type (2019-2024)
Table 57. Global Folic Acid Tablets Revenue Market Share by Type (2025-2030)
Table 58. Global Folic Acid Tablets Price (US$/Pcs) by Type (2019-2024)
Table 59. Global Folic Acid Tablets Price (US$/Pcs) by Type (2025-2030)
Table 60. Global Folic Acid Tablets Sales (M Pcs) by Application (2019-2024)
Table 61. Global Folic Acid Tablets Sales (M Pcs) by Application (2025-2030)
Table 62. Global Folic Acid Tablets Sales Market Share by Application (2019-2024)
Table 63. Global Folic Acid Tablets Sales Market Share by Application (2025-2030)
Table 64. Global Folic Acid Tablets Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Folic Acid Tablets Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Folic Acid Tablets Revenue Market Share by Application (2019-2024)
Table 67. Global Folic Acid Tablets Revenue Market Share by Application (2025-2030)
Table 68. Global Folic Acid Tablets Price (US$/Pcs) by Application (2019-2024)
Table 69. Global Folic Acid Tablets Price (US$/Pcs) by Application (2025-2030)
Table 70. Bayer Corporation Information
Table 71. Bayer Description and Business Overview
Table 72. Bayer Folic Acid Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 73. Bayer Folic Acid Tablets Product
Table 74. Bayer Recent Developments/Updates
Table 75. A＆Z Pharmaceutical Corporation Information
Table 76. A＆Z Pharmaceutical Description and Business Overview
Table 77. A＆Z Pharmaceutical Folic Acid Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 78. A＆Z Pharmaceutical Folic Acid Tablets Product
Table 79. A＆Z Pharmaceutical Recent Developments/Updates
Table 80. Endo International Corporation Information
Table 81. Endo International Description and Business Overview
Table 82. Endo International Folic Acid Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 83. Endo International Folic Acid Tablets Product
Table 84. Endo International Recent Developments/Updates
Table 85. Cardinal Health Corporation Information
Table 86. Cardinal Health Description and Business Overview
Table 87. Cardinal Health Folic Acid Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 88. Cardinal Health Folic Acid Tablets Product
Table 89. Cardinal Health Recent Developments/Updates
Table 90. Leading Pharma, LLC Corporation Information
Table 91. Leading Pharma, LLC Description and Business Overview
Table 92. Leading Pharma, LLC Folic Acid Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 93. Leading Pharma, LLC Folic Acid Tablets Product
Table 94. Leading Pharma, LLC Recent Developments/Updates
Table 95. Meiaojian Corporation Information
Table 96. Meiaojian Description and Business Overview
Table 97. Meiaojian Folic Acid Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 98. Meiaojian Folic Acid Tablets Product
Table 99. Meiaojian Recent Developments/Updates
Table 100. Sunota Corporation Information
Table 101. Sunota Description and Business Overview
Table 102. Sunota Folic Acid Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 103. Sunota Folic Acid Tablets Product
Table 104. Sunota Recent Developments/Updates
Table 105. Scrianen Corporation Information
Table 106. Scrianen Description and Business Overview
Table 107. Scrianen Folic Acid Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 108. Scrianen Folic Acid Tablets Product
Table 109. Scrianen Recent Developments/Updates
Table 110. Fishburg Corporation Information
Table 111. Fishburg Description and Business Overview
Table 112. Fishburg Folic Acid Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 113. Fishburg Folic Acid Tablets Product
Table 114. Fishburg Recent Developments/Updates
Table 115. Meydunlg Corporation Information
Table 116. Meydunlg Description and Business Overview
Table 117. Meydunlg Folic Acid Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 118. Meydunlg Folic Acid Tablets Product
Table 119. Meydunlg Recent Developments/Updates
Table 120. Elevit Corporation Information
Table 121. Elevit Description and Business Overview
Table 122. Elevit Folic Acid Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 123. Elevit Folic Acid Tablets Product
Table 124. Elevit Recent Developments/Updates
Table 125. Natures Bounty Corporation Information
Table 126. Natures Bounty Description and Business Overview
Table 127. Natures Bounty Folic Acid Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 128. Natures Bounty Folic Acid Tablets Product
Table 129. Natures Bounty Recent Developments/Updates
Table 130. Forceval Corporation Information
Table 131. Forceval Description and Business Overview
Table 132. Forceval Folic Acid Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 133. Forceval Folic Acid Tablets Product
Table 134. Forceval Recent Developments/Updates
Table 135. Nutrilite Corporation Information
Table 136. Nutrilite Description and Business Overview
Table 137. Nutrilite Folic Acid Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 138. Nutrilite Folic Acid Tablets Product
Table 139. Nutrilite Recent Developments/Updates
Table 140. Osteroform Corporation Information
Table 141. Osteroform Description and Business Overview
Table 142. Osteroform Folic Acid Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 143. Osteroform Folic Acid Tablets Product
Table 144. Osteroform Recent Developments/Updates
Table 145. Ferguson Corporation Information
Table 146. Ferguson Description and Business Overview
Table 147. Ferguson Folic Acid Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 148. Ferguson Folic Acid Tablets Product
Table 149. Ferguson Recent Developments/Updates
Table 150. By-Health Corporation Information
Table 151. By-Health Description and Business Overview
Table 152. By-Health Folic Acid Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 153. By-Health Folic Acid Tablets Product
Table 154. By-Health Recent Developments/Updates
Table 155. Lisheng Pharmaceutical Corporation Information
Table 156. Lisheng Pharmaceutical Description and Business Overview
Table 157. Lisheng Pharmaceutical Folic Acid Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 158. Lisheng Pharmaceutical Folic Acid Tablets Product
Table 159. Lisheng Pharmaceutical Recent Developments/Updates
Table 160. Renhe Pharmacy Corporation Information
Table 161. Renhe Pharmacy Description and Business Overview
Table 162. Renhe Pharmacy Folic Acid Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 163. Renhe Pharmacy Folic Acid Tablets Product
Table 164. Renhe Pharmacy Recent Developments/Updates
Table 165. SAN JIU ENTERPRISE GROUP Corporation Information
Table 166. SAN JIU ENTERPRISE GROUP Description and Business Overview
Table 167. SAN JIU ENTERPRISE GROUP Folic Acid Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2019-2024)
Table 168. SAN JIU ENTERPRISE GROUP Folic Acid Tablets Product
Table 169. SAN JIU ENTERPRISE GROUP Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Folic Acid Tablets Distributors List
Table 173. Folic Acid Tablets Customers List
Table 174. Folic Acid Tablets Market Trends
Table 175. Folic Acid Tablets Market Drivers
Table 176. Folic Acid Tablets Market Challenges
Table 177. Folic Acid Tablets Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Folic Acid Tablets
Figure 2. Global Folic Acid Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Folic Acid Tablets Market Share by Type in 2023 & 2030
Figure 4. 1mg Product Picture
Figure 5. 5mg Product Picture
Figure 6. Other Product Picture
Figure 7. Global Folic Acid Tablets Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Folic Acid Tablets Market Share by Application in 2023 & 2030
Figure 9. Pregnancy Lady
Figure 10. Pregnant Lady
Figure 11. Lactating Lady
Figure 12. Child
Figure 13. Men
Figure 14. General
Figure 15. Other
Figure 16. Global Folic Acid Tablets Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Folic Acid Tablets Market Size (2019-2030) & (US$ Million)
Figure 18. Global Folic Acid Tablets Sales (2019-2030) & (M Pcs)
Figure 19. Global Folic Acid Tablets Average Price (US$/Pcs) & (2019-2030)
Figure 20. Folic Acid Tablets Report Years Considered
Figure 21. Folic Acid Tablets Sales Share by Manufacturers in 2023
Figure 22. Global Folic Acid Tablets Revenue Share by Manufacturers in 2023
Figure 23. The Global 5 and 10 Largest Folic Acid Tablets Players: Market Share by Revenue in 2023
Figure 24. Folic Acid Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 25. Global Folic Acid Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 26. North America Folic Acid Tablets Sales Market Share by Country (2019-2030)
Figure 27. North America Folic Acid Tablets Revenue Market Share by Country (2019-2030)
Figure 28. U.S. Folic Acid Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Canada Folic Acid Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Europe Folic Acid Tablets Sales Market Share by Country (2019-2030)
Figure 31. Europe Folic Acid Tablets Revenue Market Share by Country (2019-2030)
Figure 32. Germany Folic Acid Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. France Folic Acid Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. U.K. Folic Acid Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Italy Folic Acid Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Russia Folic Acid Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Asia Pacific Folic Acid Tablets Sales Market Share by Region (2019-2030)
Figure 38. Asia Pacific Folic Acid Tablets Revenue Market Share by Region (2019-2030)
Figure 39. China Folic Acid Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Japan Folic Acid Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. South Korea Folic Acid Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. India Folic Acid Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Australia Folic Acid Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Taiwan Folic Acid Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Indonesia Folic Acid Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Thailand Folic Acid Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Malaysia Folic Acid Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Philippines Folic Acid Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Latin America Folic Acid Tablets Sales Market Share by Country (2019-2030)
Figure 50. Latin America Folic Acid Tablets Revenue Market Share by Country (2019-2030)
Figure 51. Mexico Folic Acid Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Brazil Folic Acid Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Argentina Folic Acid Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Middle East & Africa Folic Acid Tablets Sales Market Share by Country (2019-2030)
Figure 55. Middle East & Africa Folic Acid Tablets Revenue Market Share by Country (2019-2030)
Figure 56. Turkey Folic Acid Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Saudi Arabia Folic Acid Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. UAE Folic Acid Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 59. Global Sales Market Share of Folic Acid Tablets by Type (2019-2030)
Figure 60. Global Revenue Market Share of Folic Acid Tablets by Type (2019-2030)
Figure 61. Global Folic Acid Tablets Price (US$/Pcs) by Type (2019-2030)
Figure 62. Global Sales Market Share of Folic Acid Tablets by Application (2019-2030)
Figure 63. Global Revenue Market Share of Folic Acid Tablets by Application (2019-2030)
Figure 64. Global Folic Acid Tablets Price (US$/Pcs) by Application (2019-2030)
Figure 65. Folic Acid Tablets Value Chain
Figure 66. Folic Acid Tablets Production Process
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Distributors Profiles
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
